| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Neoplasms, Experimental | 21 | 2018 | 239 | 2.770 |
Why?
|
| Mammary Glands, Animal | 18 | 2018 | 451 | 2.280 |
Why?
|
| Tumor Suppressor Protein p53 | 13 | 2018 | 772 | 1.100 |
Why?
|
| Breast Neoplasms | 16 | 2018 | 2674 | 1.020 |
Why?
|
| Precancerous Conditions | 6 | 2012 | 278 | 1.010 |
Why?
|
| Carcinogens | 8 | 2009 | 128 | 0.900 |
Why?
|
| Mammary Neoplasms, Animal | 6 | 2011 | 137 | 0.840 |
Why?
|
| Progesterone | 7 | 2005 | 450 | 0.680 |
Why?
|
| Neoplastic Stem Cells | 5 | 2016 | 348 | 0.630 |
Why?
|
| Neoplasm Transplantation | 6 | 2014 | 383 | 0.630 |
Why?
|
| Estrogens | 5 | 2005 | 435 | 0.610 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2012 | 75 | 0.590 |
Why?
|
| Mammary Glands, Human | 4 | 2012 | 81 | 0.570 |
Why?
|
| Mice | 38 | 2019 | 18534 | 0.490 |
Why?
|
| Stromal Cells | 3 | 2014 | 302 | 0.480 |
Why?
|
| Mice, Inbred BALB C | 14 | 2018 | 1050 | 0.480 |
Why?
|
| Estrogen Receptor alpha | 5 | 2013 | 439 | 0.440 |
Why?
|
| Tamoxifen | 4 | 2018 | 354 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 2061 | 0.430 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 7 | 2009 | 52 | 0.420 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2014 | 31 | 0.420 |
Why?
|
| Morphogenesis | 2 | 2012 | 203 | 0.410 |
Why?
|
| Tetrahydronaphthalenes | 2 | 2012 | 29 | 0.400 |
Why?
|
| Epithelial Cells | 10 | 2013 | 903 | 0.390 |
Why?
|
| Animals | 43 | 2019 | 34908 | 0.390 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 37 | 0.380 |
Why?
|
| Antigens, CD | 1 | 2014 | 436 | 0.370 |
Why?
|
| Proteoglycans | 1 | 2012 | 92 | 0.370 |
Why?
|
| Laminin | 1 | 2012 | 72 | 0.370 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 54 | 0.360 |
Why?
|
| Glycoproteins | 1 | 2014 | 377 | 0.360 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 126 | 0.360 |
Why?
|
| Aneuploidy | 4 | 2013 | 143 | 0.350 |
Why?
|
| Collagen | 1 | 2012 | 309 | 0.340 |
Why?
|
| Mammary Tumor Virus, Mouse | 3 | 2013 | 101 | 0.340 |
Why?
|
| Peptides | 1 | 2014 | 845 | 0.330 |
Why?
|
| Models, Biological | 2 | 2012 | 1441 | 0.310 |
Why?
|
| Anticarcinogenic Agents | 2 | 2009 | 48 | 0.300 |
Why?
|
| Chromosomal Instability | 3 | 2008 | 60 | 0.300 |
Why?
|
| Estradiol | 3 | 2014 | 488 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2018 | 634 | 0.280 |
Why?
|
| Quinazolines | 1 | 2009 | 187 | 0.280 |
Why?
|
| Breast | 3 | 2007 | 215 | 0.280 |
Why?
|
| Receptors, Estrogen | 5 | 2018 | 740 | 0.260 |
Why?
|
| Sulfonamides | 1 | 2009 | 283 | 0.260 |
Why?
|
| Genes, p53 | 3 | 2007 | 221 | 0.260 |
Why?
|
| Disease Models, Animal | 7 | 2013 | 4688 | 0.260 |
Why?
|
| Cell Growth Processes | 5 | 2013 | 65 | 0.250 |
Why?
|
| Pyrazoles | 1 | 2009 | 330 | 0.250 |
Why?
|
| Mice, Inbred NOD | 4 | 2016 | 316 | 0.240 |
Why?
|
| Mice, SCID | 4 | 2016 | 604 | 0.230 |
Why?
|
| Hyperplasia | 5 | 2008 | 195 | 0.230 |
Why?
|
| Female | 40 | 2021 | 70607 | 0.220 |
Why?
|
| Cell Cycle Proteins | 7 | 2008 | 685 | 0.210 |
Why?
|
| Cell Cycle | 3 | 2014 | 608 | 0.210 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2003 | 99 | 0.190 |
Why?
|
| Carcinogens, Environmental | 1 | 2002 | 13 | 0.190 |
Why?
|
| Progestins | 1 | 2002 | 45 | 0.180 |
Why?
|
| Separase | 3 | 2013 | 29 | 0.180 |
Why?
|
| Rats | 8 | 2010 | 3606 | 0.180 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2018 | 265 | 0.180 |
Why?
|
| Founder Effect | 1 | 2021 | 35 | 0.170 |
Why?
|
| Hydatidiform Mole | 1 | 2021 | 20 | 0.170 |
Why?
|
| Injections, Intralesional | 2 | 2019 | 47 | 0.170 |
Why?
|
| Graft Survival | 2 | 2012 | 471 | 0.160 |
Why?
|
| Cell Division | 5 | 2004 | 744 | 0.160 |
Why?
|
| Mice, Transgenic | 7 | 2015 | 2450 | 0.160 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2019 | 42 | 0.150 |
Why?
|
| Cyclins | 3 | 2004 | 100 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 5 | 2012 | 249 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1828 | 0.140 |
Why?
|
| Humans | 27 | 2021 | 131930 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 623 | 0.130 |
Why?
|
| Epithelium | 2 | 2012 | 354 | 0.130 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2016 | 11 | 0.130 |
Why?
|
| Autocrine Communication | 1 | 2016 | 29 | 0.130 |
Why?
|
| Mice, Knockout | 6 | 2009 | 3866 | 0.130 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2016 | 36 | 0.120 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 49 | 0.120 |
Why?
|
| Endopeptidases | 2 | 2008 | 114 | 0.120 |
Why?
|
| Cell Line, Tumor | 7 | 2016 | 3688 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 148 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2010 | 323 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 498 | 0.110 |
Why?
|
| Cell Differentiation | 3 | 2012 | 1963 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2016 | 816 | 0.110 |
Why?
|
| Neoplasms | 2 | 2019 | 2953 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2007 | 492 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 212 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2019 | 748 | 0.110 |
Why?
|
| AC133 Antigen | 1 | 2014 | 37 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 156 | 0.110 |
Why?
|
| Disease Progression | 3 | 2013 | 2222 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 133 | 0.110 |
Why?
|
| Leukocyte Common Antigens | 1 | 2014 | 91 | 0.110 |
Why?
|
| Pregnancy | 8 | 2021 | 7545 | 0.110 |
Why?
|
| Cell Survival | 1 | 2016 | 869 | 0.100 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 97 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 87 | 0.100 |
Why?
|
| Culture Media | 1 | 2014 | 182 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2014 | 238 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2013 | 1080 | 0.100 |
Why?
|
| 14-3-3 Proteins | 1 | 2013 | 57 | 0.100 |
Why?
|
| Heterozygote | 2 | 2021 | 714 | 0.100 |
Why?
|
| Immunophenotyping | 1 | 2014 | 343 | 0.100 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2013 | 47 | 0.100 |
Why?
|
| Antigens, CD19 | 1 | 2014 | 182 | 0.100 |
Why?
|
| Cell Size | 1 | 2013 | 85 | 0.100 |
Why?
|
| Nicotinic Acids | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cell Proliferation | 5 | 2016 | 2509 | 0.100 |
Why?
|
| Cell Separation | 1 | 2013 | 226 | 0.090 |
Why?
|
| Apoptosis | 4 | 2014 | 1900 | 0.090 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 56 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2014 | 86 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 358 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 58 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2012 | 47 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 1719 | 0.090 |
Why?
|
| Fetal Blood | 1 | 2012 | 174 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 26 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2012 | 280 | 0.090 |
Why?
|
| Transcriptome | 1 | 2018 | 1122 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3044 | 0.090 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2010 | 45 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 662 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 308 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 308 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 722 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 1993 | 0.080 |
Why?
|
| Parity | 1 | 2010 | 85 | 0.080 |
Why?
|
| Sarcoma | 1 | 2012 | 208 | 0.080 |
Why?
|
| Growth Hormone | 1 | 2010 | 129 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 856 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 2850 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 1017 | 0.080 |
Why?
|
| Celecoxib | 1 | 2009 | 32 | 0.080 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2009 | 53 | 0.070 |
Why?
|
| Wnt1 Protein | 1 | 2009 | 74 | 0.070 |
Why?
|
| Melanoma | 1 | 2016 | 954 | 0.070 |
Why?
|
| Chloroquine | 1 | 2007 | 31 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 551 | 0.070 |
Why?
|
| Stem Cells | 1 | 2013 | 732 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2019 | 813 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2007 | 72 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2009 | 295 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 127 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1577 | 0.070 |
Why?
|
| Lactation | 2 | 2005 | 198 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 6245 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 6435 | 0.060 |
Why?
|
| Incidence | 3 | 2013 | 3362 | 0.060 |
Why?
|
| Centrosome | 2 | 2007 | 27 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2004 | 60 | 0.060 |
Why?
|
| Phenotype | 3 | 2013 | 4538 | 0.060 |
Why?
|
| Risk | 1 | 2008 | 761 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2018 | 755 | 0.060 |
Why?
|
| Mad2 Proteins | 1 | 2004 | 8 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 161 | 0.060 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 12 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 604 | 0.050 |
Why?
|
| Carcinoma | 1 | 2007 | 300 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2013 | 802 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 998 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 133 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4757 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 333 | 0.050 |
Why?
|
| Genomics | 1 | 2011 | 1652 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2007 | 445 | 0.050 |
Why?
|
| Base Sequence | 2 | 2004 | 2897 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2002 | 35 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2013 | 1613 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2003 | 170 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3358 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 681 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2014 | 2676 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2002 | 51 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2002 | 74 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2002 | 146 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 474 | 0.040 |
Why?
|
| Live Birth | 1 | 2021 | 72 | 0.040 |
Why?
|
| CD24 Antigen | 2 | 2013 | 33 | 0.040 |
Why?
|
| Integrin beta1 | 2 | 2013 | 56 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 590 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 864 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 185 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2002 | 331 | 0.040 |
Why?
|
| Models, Animal | 1 | 2002 | 469 | 0.040 |
Why?
|
| Rats, Inbred WF | 3 | 2007 | 16 | 0.040 |
Why?
|
| Aging | 1 | 2007 | 1252 | 0.040 |
Why?
|
| Squalene | 1 | 2019 | 25 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 31 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1683 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 770 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 545 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 203 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2019 | 188 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 1285 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 20 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 1478 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 328 | 0.040 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 189 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 392 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 209 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 699 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 449 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 543 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 537 | 0.030 |
Why?
|
| Pregnancy, Animal | 2 | 2010 | 72 | 0.030 |
Why?
|
| Genotype | 1 | 2002 | 2703 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2005 | 2487 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 100 | 0.030 |
Why?
|
| Methylnitrosourea | 2 | 2007 | 15 | 0.030 |
Why?
|
| Aurora Kinases | 2 | 2007 | 27 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 688 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 7113 | 0.030 |
Why?
|
| Aurora Kinase A | 2 | 2007 | 37 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 1045 | 0.030 |
Why?
|
| Vaccination | 1 | 2019 | 1017 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2015 | 4717 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 378 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 120 | 0.030 |
Why?
|
| Cyclin D1 | 2 | 2005 | 113 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 217 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2014 | 140 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 139 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2019 | 700 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 410 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 424 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 63 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2014 | 302 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 242 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 201 | 0.020 |
Why?
|
| Biomarkers | 2 | 2013 | 3373 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 897 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 774 | 0.020 |
Why?
|
| Lung | 1 | 2019 | 1556 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 679 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 578 | 0.020 |
Why?
|
| Galactosides | 1 | 2011 | 11 | 0.020 |
Why?
|
| Claudins | 1 | 2011 | 31 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 358 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 955 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 248 | 0.020 |
Why?
|
| Risk Factors | 1 | 2005 | 10893 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 88 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 1876 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 182 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 648 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 541 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 430 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1540 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 304 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2010 | 329 | 0.020 |
Why?
|
| Metaphase | 1 | 2008 | 33 | 0.020 |
Why?
|
| Anaphase | 1 | 2008 | 13 | 0.020 |
Why?
|
| Chromatids | 1 | 2008 | 32 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 69 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2008 | 42 | 0.020 |
Why?
|
| Tetracycline | 1 | 2008 | 80 | 0.020 |
Why?
|
| Nucleotidyltransferases | 1 | 2008 | 49 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 218 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 21394 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 826 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 311 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 60 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2007 | 70 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 100 | 0.020 |
Why?
|
| Polyploidy | 1 | 2007 | 18 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1224 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1303 | 0.020 |
Why?
|
| Karyotyping | 1 | 2007 | 317 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 548 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 28893 | 0.020 |
Why?
|
| United States | 1 | 2002 | 11619 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 457 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2724 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 124 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 117 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1033 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 31506 | 0.010 |
Why?
|
| Menopause | 1 | 2005 | 90 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 2005 | 81 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2007 | 403 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 57 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 1331 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2011 | 916 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2005 | 259 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 5143 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 114 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 2002 | 15 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 503 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 60 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 90 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 139 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2002 | 101 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 613 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 453 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 880 | 0.010 |
Why?
|
| Male | 3 | 2016 | 64846 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 1563 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 596 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 1552 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9929 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 2670 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 1017 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3771 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2002 | 822 | 0.010 |
Why?
|